Herb Profile

Myristica Fragrans

Myristica fragrans

Myristica Fragrans (Myristica fragrans) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Digestive, Sedative, Sleep quality, Cognitive function
Avoid / review if
Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Potential Interaction Concern With Antihypertensives/Diuretics
Myristica Fragrans monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
High-dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.
Profile context
digestive, sedative
Next steps

Continue reading

Safety

Safety & Cautions

High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy/Breastfeeding Without Clinician Supervision
  • Known Allergy To The Plant/Family
  • Potential Interaction Concern With Antihypertensives/Diuretics
  • Sedatives/CNS Depressants
  • Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.

Safety labels

  • Interaction-Aware
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Moderate Caution

149 flagged pairings

Blood-pressure effects · Sedation / CNS depression

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedNeurotransmitter Modulation

Research maturity: Emerging researchLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableHigh dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Systematic review
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a systematic review, drawn from 5 recorded studies, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (5)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 1 human evidence source; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

PMID 41322721

Background
Systematic review

Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.

A 2025/2026 systematic review of medicinal/edible seed safety identified 703 adverse events across eight seed medicines; Myristicae semen contributed one serious adverse event. Most events across the dataset involved children or excessive intake. These counts do not establish nutmeg-specific incidence but strengthen overdose/child-safety warnings.PubMed

Nutmeg (Myristica fragrans Houtt.) essential oil: A review on its composition, biological, and pharmacological activities

Ashokkumar K et al. · Phytother Res · 2022

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Nutmeg

PubMed indexed authors · 2006

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review

Ha MT et al. · Arch Pharm Res · 2020

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

A toxicology review documents neuropsychiatric and autonomic intoxication after gram-level nutmeg ingestion. These reports are toxicity observations—not a safe-use threshold—and support explicit overdose/intoxication warnings.

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

A toxicology review documents neuropsychiatric and autonomic intoxication after gram-level nutmeg ingestion. These reports are toxicity observations—not a safe-use threshold—and support explicit overdose/intoxication warnings.PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Myristica Fragrans works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Myristica Fragrans Works

How Myristica Fragrans WorksMyristica Fragrans acts on biological target pathways via neurotransmitter (modulation), leading to digestive.Myristica FragransBiological TargetBiological pathwayNeurotransmitterModulationDigestiveObservable outcome
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

  • Neurotransmitter Modulation

Active Compounds

Key constituents studied in Myristica Fragrans, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Myristica Fragrans

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Myristica Fragrans

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Myristica Fragrans research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Botanical profile context

How to interpret Myristica Fragrans

Myristica Fragrans herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Myristica Fragrans, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.